Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer

Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01111032

Enrollment

Registered

2010-04-27

Start date

2011-05-31

Completion date

2011-12-31

Last updated

2013-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Treadmill, Exercise, Cancer, Validity, Reliability

Brief summary

During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

16 Years to No maximum

Healthy volunteers

Inclusion criteria

* Participants are required to be adults (age 16 or over), * Diagnosed with cancer, at any stage of treatment (during or after treatment), * Able to follow instructions in English, and provide informed consent. * Participants need to be considered well to participate. A well participant has been defined as a cancer survivor who is living at home, able to ambulate independently without a gait aid (single point cane is acceptable), has no acute medical conditions, and passes pre-exercise safety screening.

Exclusion criteria

* Cancer survivors with metastatic disease. * Cancer survivors who are defined as unwell.

Design outcomes

Primary

Measure	Time frame	Description
STEEP treadmill test	1 hour	Treadmill test for endurance. Lasts approx 15 min with 45 min recovery

Countries

Canada

Outcome results